Standard InChI: InChI=1S/C32H28ClN3O5/c33-27-12-23(17-36-28(18-37)32(38)39)30(40-19-21-11-20(14-34)15-35-16-21)13-31(27)41-29-10-9-25-24(7-4-8-26(25)29)22-5-2-1-3-6-22/h1-8,11-13,15-16,28-29,36-37H,9-10,17-19H2,(H,38,39)/t28-,29?/m0/s1
1.Chen H, Wang K, Yang Y, Huang X, Dai X, Feng Z.. (2021) Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold., 217 [PMID:33770574][10.1016/j.ejmech.2021.113377]
2.Huang X, Chen H, Dai X, Xu M, Wang K, Feng Z.. (2021) Design, synthesis, and structure-activity relationship of PD-1/PD-L1 inhibitors with a benzo[d]isoxazole scaffold., 52 [PMID:34610423][10.1016/j.bmcl.2021.128403]
3.Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X.. (2021) If small molecules immunotherapy comes, can the prime be far behind?, 218 [PMID:33773287][10.1016/j.ejmech.2021.113356]